{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:43:29Z","timestamp":1792107809907,"version":"4.4.0"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>With continuing occurrence of varicella despite increasing vaccine coverage for the past 20 years, a case-based study, a case-control study, and an immunogenicity and safety study were conducted to address the impact of varicella vaccination in South Korea. Varicella patients under the age of 16 years were enrolled for the case-based study. For the case-control study, varicella patients between 12 months and 15 years of age were enrolled with one control matched for each patient. For the immunogenicity and safety study, otherwise healthy children from 12 to 24 months old were immunized with Suduvax (Green Cross, South Korea). Fluorescent antibody to membrane antigen (FAMA) varicella-zoster virus (VZV) antibody was measured before and 6 weeks after immunization. In the case-based study, the median age of the patients was 4 years. Among 152 patients between 1 and 15 years of age, 139 children received varicella vaccine and all had breakthrough infections. Clinical courses were not ameliorated in vaccinated patients, but more vaccinated patients received outpatient rather than inpatient care. In the case-control study, the adjusted overall effectiveness of varicella vaccination was 54%. In the immunogenicity and safety study, the seroconversion rate and geometric mean titer for FAMA antibody were 76.67% and 5.31. Even with increasing varicella vaccine uptake, we illustrate no upward age shift in the peak incidence, a high proportion of breakthrough disease, almost no amelioration in disease presentation by vaccination, and insufficient immunogenicity of domestic varicella vaccine. There is need to improve the varicella vaccine used in South Korea.<\/jats:p>","DOI":"10.1128\/cvi.00645-13","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T03:45:45Z","timestamp":1395891945000},"page":"762-768","source":"Crossref","is-referenced-by-count":52,"title":["Varicella and Varicella Vaccination in South Korea"],"prefix":"10.1128","volume":"21","author":[{"given":"Sung Hee","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hwa","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Hee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Keun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Min","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Kyun","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Youn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hee","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungho","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Nam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hyuk","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Wook","family":"Eun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Sun","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Youl","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2014,3,26]]},"reference":[{"key":"key20180919073732_B1","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"V\u00e1zquez","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"key20180919073732_B2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/1471-2334-13-303","article-title":"Varicella routine vaccination and the effects on varicella epidemiology\u2014results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011","volume":"13","author":"Streng","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"key20180919073732_B3","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1016\/j.vaccine.2013.08.022","article-title":"The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates","volume":"31","author":"Waye","year":"2013","journal-title":"Vaccine"},{"key":"key20180919073732_B4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/INF.0b013e31827e92b7","article-title":"Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia","volume":"32","author":"Marshall","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"key20180919073732_B5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/1471-2334-11-352","article-title":"Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan","volume":"11","author":"Chang","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"key20180919073732_B6","first-page":"1","article-title":"Case definitions for infectious conditions under public health surveillance","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"key20180919073732_B7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1542\/peds.92.6.833","article-title":"Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka\/Merck varicella vaccine","volume":"92","author":"Bernstein","year":"1993","journal-title":"Pediatrics"},{"key":"key20180919073732_B8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/infdis\/130.6.669","article-title":"Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence","volume":"130","author":"Williams","year":"1974","journal-title":"J. Infect. Dis."},{"key":"key20180919073732_B9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicella vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"J. Infect. Dis."},{"key":"key20180919073732_B10","volume-title":"Vaccine schedule selection form","author":"World Health Organization","year":"2013"},{"key":"key20180919073732_B11","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites\u2014United States, 1995-2005","volume":"197","author":"Guris","year":"2008","journal-title":"J. Infect. Dis."},{"key":"key20180919073732_B12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"key20180919073732_B13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1542\/peds.2010-0962","article-title":"Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era","volume":"127","author":"Lopez","year":"2011","journal-title":"Pediatrics"},{"key":"key20180919073732_B14","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm. Rep."},{"key":"key20180919073732_B15","doi-asserted-by":"publisher","first-page":"e1134","DOI":"10.1542\/peds.2013-0863","article-title":"Impact of a routine two-dose varicella vaccination program on varicella epidemiology","volume":"132","author":"Bialek","year":"2013","journal-title":"Pediatrics"},{"key":"key20180919073732_B16","first-page":"620","article-title":"Epidemiology of varicella in Korea based on pediatrician's office practice","volume":"40","author":"Kim","year":"1997","journal-title":"J. Korean Pediatr. Soc."},{"key":"key20180919073732_B17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.14776\/kjpid.1998.5.1.88","article-title":"A clinical and epidemiologic study on varicella in children","volume":"5","author":"Kim","year":"1998","journal-title":"Korean J. Pediatr. Infect. Dis."},{"key":"key20180919073732_B18","volume-title":"Development of vaccination coverage estimation methods and evaluation indicators of national immunization program in Korea","author":"Korea Centers for Disease Control and Prevention","year":"2005"},{"key":"key20180919073732_B19","first-page":"90","article-title":"Vaccination coverage in Korean children of six years old and younger","author":"Lee","year":"2007"},{"key":"key20180919073732_B20","volume-title":"Korea national immunization survey","author":"Lee","year":"2011"},{"key":"key20180919073732_B21","volume-title":"Infectious diseases surveillance yearbook 2011 public health weekly report","author":"Korea Centers for Disease Control and Prevention","year":"2011"},{"key":"key20180919073732_B22","unstructured":"National Health Insurance Service. 2011. Statistical yearbook. National Health Insurance Service, Health Insurance Review & Assessment Service. http:\/\/www.nhis.or.kr\/portal\/site\/main\/MENU_WBDDG02\/."},{"key":"key20180919073732_B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00006454-199201000-00006","article-title":"Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response","volume":"11","author":"White","year":"1992","journal-title":"Pediatr. Infect. Dis. J."},{"key":"key20180919073732_B24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1086\/341089","article-title":"Younger age at vaccination may increase risk of varicella vaccine failure","volume":"186","author":"Galil","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"2","key":"key20180919073732_B25","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1542\/peds.112.2.e98","article-title":"A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination","volume":"112","author":"Verstraeten","year":"2003","journal-title":"Pediatrics"},{"key":"key20180919073732_B26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"V\u00e1zquez","year":"2004","journal-title":"JAMA"},{"key":"key20180919073732_B27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1542\/peds.92.6.833","article-title":"Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka\/Merck varicella vaccine","volume":"92","author":"Bernstein","year":"1993","journal-title":"Pediatrics"},{"key":"key20180919073732_B28","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/jama.278.18.1495","article-title":"Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center","volume":"278","author":"Izurieta","year":"1997","journal-title":"JAMA"},{"key":"key20180919073732_B29","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/00006454-199912000-00004","article-title":"Postlicensure study of varicella vaccine effectiveness in a day-care setting","volume":"18","author":"Clements","year":"1999","journal-title":"Pediatr. Infect. Dis. J."},{"key":"key20180919073732_B30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1542\/peds.104.3.561","article-title":"Varicella outbreaks after vaccine licensure: should they make you chicken?","volume":"104","author":"Buchholz","year":"1999","journal-title":"Pediatrics"},{"key":"key20180919073732_B31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1542\/peds.113.3.455","article-title":"Chickenpox outbreak in a highly vaccinated school population","volume":"113","author":"Tugwell","year":"2004","journal-title":"Pediatrics"},{"key":"key20180919073732_B32","first-page":"389","article-title":"Outbreak of varicella among vaccinated children\u2014Michigan, 2003","volume":"53","author":"Centers for Disease Control and Prevention (CDC)","year":"2004","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"key20180919073732_B33","doi-asserted-by":"publisher","first-page":"e1070","DOI":"10.1542\/peds.2005-2085","article-title":"One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?","volume":"117","author":"Lopez","year":"2006","journal-title":"Pediatrics"},{"key":"key20180919073732_B34","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the U.S. vaccination program: a review","volume":"197","author":"Seward","year":"2008","journal-title":"J. Infect. Dis."},{"key":"key20180919073732_B35","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination","volume":"347","author":"Galil","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"key20180919073732_B36","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/INF.0b013e31829ae263","article-title":"Thee effectiveness of varicella vaccination in children in Germany: a case-control study","volume":"32","author":"Liese","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"key20180919073732_B37","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1016\/j.vaccine.2011.01.092","article-title":"Varicella breakthrough infection and vaccine effectiveness in Taiwan","volume":"29","author":"Huang","year":"2011","journal-title":"Vaccine"},{"key":"key20180919073732_B38","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/INF.0b013e3181d7380e","article-title":"The effectiveness of varicella vaccine in China","volume":"29","author":"Fu","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"key20180919073732_B39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/01.inf.0000160947.89942.30","article-title":"Effectiveness of the Oka\/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel","volume":"24","author":"Sheffer","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"key20180919073732_B40","first-page":"201","article-title":"Restriction fragment length polymorphism analysis of varicella-zoster virus isolated in Korea","volume":"21","author":"Hwang","year":"1991","journal-title":"J. Korean Soc. Virol."},{"key":"key20180919073732_B41","first-page":"105","article-title":"Marker test for attenuation of varicella-zoster viruses isolated in Korea","volume":"22","author":"Hwang","year":"1992","journal-title":"J. Korean Soc. Virol."},{"key":"key20180919073732_B42","first-page":"1405","article-title":"Safety and immunogenicity of live attenuated varicella virus vaccine (MAV\/06 strain)","volume":"37","author":"Sohn","year":"1994","journal-title":"J. Korean Pediatr. Soc."},{"key":"key20180919073732_B43","first-page":"771","article-title":"Immunogenicity and safety of live attenuated varicella vaccine (MAV\/06 strain) on healthy children and immunocompromised children","volume":"38","author":"Sohn","year":"1995","journal-title":"J. Korean Pediatr. Soc."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00645-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T02:38:07Z","timestamp":1648694287000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00645-13"}},"subtitle":[],"editor":[{"given":"S. A.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,26]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,2]]},"published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1128\/CVI.00645-13"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00645-13","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,26]]}}}